Companies: 10,795·Total market cap: $144.5T
Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

VNDANASDAQHealthcare● Active
$5.94
$-0.09(-1.49%)
Market Cap$357205238
P/E Ratio
52W High$9.94
52W Low$4.14

Vanda Pharmaceuticals Inc.(VNDA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · VNDA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.22B$0.20B$0.19B$0.25B$0.27B
Cost of Revenue$0.01B$0.01B$0.01B$0.02B$0.03B
Gross Profit$0.20B$0.19B$0.18B$0.23B$0.24B
Gross Margin %(computed)93.96%94.31%92.32%90.45%90.46%
Operating Expenses
R&D Expenses$0.11B$0.07B$0.08B$0.09B$0.08B
G&A Expenses$0.00B$0.14B$0.11B$0.13B$0.12B
Total Operating Expenses$0.35B$0.23B$0.19B$0.22B$0.20B
Operating Income($0.15B)($0.04B)($0.01B)$0.01B$0.04B
Operating Margin %(computed)-69.95%-20.46%-7.24%2.49%15.69%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.14B)($0.02B)$0.01B$0.01B$0.04B
Income Tax Expense$0.08B($0.00B)$0.00B$0.01B$0.01B
Net Income($0.22B)($0.02B)$0.00B$0.01B$0.03B
Net Margin %(computed)-102.02%-9.51%1.30%2.47%12.34%
Per Share & EBITDA
EPS (Basic)$-3.74$-0.32$0.04$0.11$0.60
Wtd Avg Shares0.06B0.06B0.06B0.06B0.06B
EBITDA($0.14B)($0.03B)($0.01B)$0.01B$0.05B
EBITDA Margin %(computed)-64.44%-16.36%-5.68%3.56%16.75%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Vanda Pharmaceuticals Inc.

关于Vanda Pharmaceuticals Inc.(VNDA)损益表

Vanda Pharmaceuticals Inc.(VNDA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,VNDA实现营收$0.22B,毛利润$0.20B(毛利率93.96%),净利润($0.22B)(净利率-102.02%)。

常见问题

VNDA · 4 问

Vanda Pharmaceuticals Inc.(VNDA)2025财年营收为$0.22B,同比up8.7%。

VNDA revenueVNDA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08